FPHAX Rating, Research - Fidelity Select Pharmaceuticals

Fidelity Select Pharmaceuticals (fphax)

Last Updated by Anonymous | Update This Page Now

►Summary | Add New Mutual Fund | Feedback

Short Term Rating Stock Ratings Help

Asset Allocation (% of Port)

US Stocks
Non-US Stocks

Geographic Allocation (% of Port)

North America
South America
Australia + Pacific Islands
Long Term Rating Stock Ratings Help


SWOT Statistics

Strengths + Opportunities = 60

Threats + Weaknesses = 41

When strengths & opportunities substantially exceed threats & weaknesses an investment in the fphax mutual fund has great long term potential.

Fund Management Team

Fund Description Update

Fidelity Select Pharmaceuticals (FPHAX) Description: FPHAX is a mutual fund, which is an investment that owns a basket of assets. The FPHAX mutual fund was provided by Fidelity and this investment vehicle derives the majority of its value from equity holdings (stocks). Fidelitys mutual fund has a medium management tenure and is in the average fund size classification. FPHAXs minimum initial investment amount is $2500 while the IRA minimum is $2500. FPHAXs expense ratio is roughly 1%. The latest FPHAXs front end load was 0% and the back end load was 0%. The Fidelity Select Pharmaceuticals (FPHAX) mutual fund falls under the health category. FPHAX focuses its investments in USA and FPHAX is focused on the health industry or fund sector. The Fidelity Select Pharmaceuticals (FPHAX) mutual fund is not a leveraged fund and it does not have inverse fund properties. An investor can find FPHAXs top holdings, fundamental analysis, ratings, and fund risk (volatility) on the left side of the screen. The right side of FPHAXs research report features technical analysis and long term investment potential.

Portfolio Strategy Update

This investment vehicle seeks capital appreciation. The fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. These companies may include pharmaceutical companies and other companies involved in the research, development, manufacture, sale, or distribution of drugs, including companies that facilitate the testing or regulatory approval of drugs. It may invest in securities of foreign issuers. The funds non-diversified.

Management Analysis Update

Fidelity Select Pharmaceuticals's management team has a long history of working together. This helps ensure consistent future returns. The fphax fund does not have a history of big fund withdrawals. This helps reduce large tax payments to current investors.

Performance Analysis Update